WILD-TYPE P53 RESTORES CELL-CYCLE CONTROL AND INHIBITS GENE AMPLIFICATION IN CELLS WITH MUTANT P53 ALLELES

被引:1154
作者
YIN, YX
TAINSKY, MA
BISCHOFF, FZ
STRONG, LC
WAHL, GM
机构
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT EXPTL PEDIAT, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT TUMOR BIOL, HOUSTON, TX 77030 USA
关键词
D O I
10.1016/0092-8674(92)90244-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Loss of cell cycle control and acquisition of chromosomal rearrangements such as gene amplification often occur during tumor progression, suggesting that they may be correlated. We show here that the wild-type p53 allele is lost when fibroblasts from patients with the Li-Fraumeni syndrome (LFS) are passaged in vitro. Normal and LFS cells containing wild-type p53 arrested in G1 when challenged with the uridine biosynthesis inhibitor PALA and did not undergo PALA-selected gene amplification. The converse occurred in cells lacking wild-type p53 expression. Expression of wild-type p53 in transformants of immortal and tumor cells containing mutant p53 alleles restored G1 control and reduced the frequency of gene amplification to undetectable levels. These studies reveal that p53 contributes to a metabolically regulated G1 checkpoint, and they provide a model for understanding how abnormal cell cycle progression leads to the genetic rearrangements involved in tumor progression.
引用
收藏
页码:937 / 948
页数:12
相关论文
共 89 条
  • [1] THE AGE DISTRIBUTION OF CANCER AND A MULTI-STAGE THEORY OF CARCINOGENESIS
    ARMITAGE, P
    DOLL, R
    [J]. BRITISH JOURNAL OF CANCER, 1954, 8 (01) : 1 - 12
  • [2] AYUSAWA D, 1983, J BIOL CHEM, V258, P2448
  • [3] BAKER SJ, 1990, CANCER RES, V50, P7717
  • [4] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [5] KARYOTYPIC EVOLUTION IN HUMAN-MALIGNANT MELANOMA
    BALABAN, GB
    HERLYN, M
    CLARK, WH
    NOWELL, PC
    [J]. CANCER GENETICS AND CYTOGENETICS, 1986, 19 (1-2) : 113 - 122
  • [6] AN IMPROVED IMMUNOCYTOCHEMICAL PROCEDURE FOR HIGH-SENSITIVITY DETECTION OF INCORPORATED BROMODEOXYURIDINE
    BEISKER, W
    DOLBEARE, F
    GRAY, JW
    [J]. CYTOMETRY, 1987, 8 (02): : 235 - 239
  • [7] BIEDLER JL, 1988, CANCER RES, V48, P3179
  • [8] BISCHOFF FZ, 1990, CANCER RES, V50, P7979
  • [9] HUMAN P53 IS PHOSPHORYLATED BY P60-CDC2 AND CYCLIN-B-CDC2
    BISCHOFF, JR
    FRIEDMAN, PN
    MARSHAK, DR
    PRIVES, C
    BEACH, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4766 - 4770
  • [10] MOUSE P53 INHIBITS SV40 ORIGIN-DEPENDENT DNA-REPLICATION
    BRAITHWAITE, AW
    STURZBECHER, HW
    ADDISON, C
    PALMER, C
    RUDGE, K
    JENKINS, JR
    [J]. NATURE, 1987, 329 (6138) : 458 - 460